Adherence to American Society of Clinical Oncology (ASCO) language of respect (LoR) guidelines in ASCO Annual Meeting prostate cancer (PCa) abstracts.

Authors

Regina Barragán Carrillo

Regina Barragan-Carrillo

City of Hope Comprehensive Cancer Center, Duarte, CA

Regina Barragan-Carrillo , Megan Hoikei Wong , Nazli Dizman , Daniela V. Castro , Benjamin D. Mercier , Xiaochen Li , Amber Faridi , Jaya Goud , Trishita Paul , Ethan Chan , Akasha Dukkipati , Teebro Paul , Miguel Zugman , Hedyeh Ebrahimi , Tanya B. Dorff , Alex Chehrazi-Raffle , Sumanta Kumar Pal , Narjust Florez , Tatiana Michelle Prowell

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 94)

DOI

10.1200/JCO.2024.42.4_suppl.94

Abstract #

94

Poster Bd #

D9

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Genitourinary Cancers Symposium

From guidelines to accountability: Examining adherence to ASCO Language of Respect in renal cell carcinoma (RCC) abstracts.

From guidelines to accountability: Examining adherence to ASCO Language of Respect in renal cell carcinoma (RCC) abstracts.

First Author: Nazli Dizman

Poster

2024 ASCO Genitourinary Cancers Symposium

Adherence to ASCO Language of Respect (LoR) guidelines in urothelial carcinoma (UC) abstracts at the 2023 ASCO Annual Meeting.

Adherence to ASCO Language of Respect (LoR) guidelines in urothelial carcinoma (UC) abstracts at the 2023 ASCO Annual Meeting.

First Author: Daniela V. Castro

Poster

2023 ASCO Genitourinary Cancers Symposium

Barriers to guideline-concordant use of bone modifying agents for prostate cancer.

Barriers to guideline-concordant use of bone modifying agents for prostate cancer.

First Author: Aaron Philip Mitchell